contents table Logo lexp
European Medicines Agency (EMA)
Article 80

Article 80


To ensure an appropriate level of transparency, the Management Board shall, on the basis of a proposal by the Executive Director and in agreement with the Commission, adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of medicinal products for human use and of veterinary medicinal products which is not of a confidential nature.


The internal rules and procedures of the Agency, its committees and its working groups shall be made available to the public at the Agency and on the Internet.